Study tests if teaching patients to manage pill side effects boosts quality of life
NCT ID NCT07258810
First seen Dec 16, 2025 · Last updated May 14, 2026 · Updated 18 times
Summary
This study looks at whether a special education program helps people with neuroendocrine tumors better manage side effects from oral cancer drugs like everolimus or sunitinib. About 100 adults will be followed for 3 months to track side effects, hospital visits, and quality of life. The goal is to see if teaching patients how to handle their own treatment improves safety and well-being.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE (NE) TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Edouard Herriot University Hospital
Lyon, 69003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.